247 related articles for article (PubMed ID: 18276620)
1. Prognostic role of echocardiography and brain natriuretic peptide in symptomatic breathless patients in the community.
Whalley GA; Wright SP; Pearl A; Gamble GD; Walsh HJ; Richards M; Doughty RN
Eur Heart J; 2008 Feb; 29(4):509-16. PubMed ID: 18276620
[TBL] [Abstract][Full Text] [Related]
2. Plasma N-terminal protype-B natriuretic peptide and restrictive mitral flow to risk-stratify patients with stage B heart failure.
Dini FL; Whalley G; Poppe K; Fontanive P; Rosa GM; Doughty RN; Di Bello V
Clin Cardiol; 2009 Dec; 32(12):711-7. PubMed ID: 20027664
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
4. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy.
Chen AA; Wood MJ; Krauser DG; Baggish AL; Tung R; Anwaruddin S; Picard MH; Januzzi JL
Eur Heart J; 2006 Apr; 27(7):839-45. PubMed ID: 16510467
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of tissue Doppler echocardiography in the emergency diagnosis of decompensated heart failure with preserved left ventricular systolic function: comparison with B-type natriuretic peptide measurement.
Arques S; Roux E; Sbragia P; Ambrosi P; Taieb L; Pieri B; Gelisse R; Luccioni R
Echocardiography; 2005 Sep; 22(8):657-64. PubMed ID: 16174119
[TBL] [Abstract][Full Text] [Related]
6. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
[TBL] [Abstract][Full Text] [Related]
7. The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study.
Betti I; Castelli G; Barchielli A; Beligni C; Boscherini V; De Luca L; Messeri G; Gheorghiade M; Maisel A; Zuppiroli A
J Card Fail; 2009 Jun; 15(5):377-84. PubMed ID: 19477397
[TBL] [Abstract][Full Text] [Related]
8. N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluationof the Evolution of New-Heart Failure Study (SCREEN-HF).
McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Krum H
Eur J Heart Fail; 2013 May; 15(5):573-80. PubMed ID: 23338855
[TBL] [Abstract][Full Text] [Related]
9. NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF).
McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Stewart S; Krum H
Int J Cardiol; 2013 Oct; 169(2):133-8. PubMed ID: 24080362
[TBL] [Abstract][Full Text] [Related]
10. Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEF.
Savarese G; Orsini N; Hage C; Vedin O; Cosentino F; Rosano GMC; Dahlström U; Lund LH
JACC Heart Fail; 2018 Mar; 6(3):246-256. PubMed ID: 29428439
[TBL] [Abstract][Full Text] [Related]
11. [Asymptomatic ischemic heart dysfunction, echocardiographic changes and NT-proBNP during 2-years observation].
Skrzypek A; Nessler J
Przegl Lek; 2014; 71(7):378-83. PubMed ID: 25338333
[TBL] [Abstract][Full Text] [Related]
12. Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study.
Jhund PS; Anand IS; Komajda M; Claggett BL; McKelvie RS; Zile MR; Carson PE; McMurray JJ
Eur J Heart Fail; 2015 Aug; 17(8):809-17. PubMed ID: 25921853
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
[TBL] [Abstract][Full Text] [Related]
14. Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study.
Weiner RB; Baggish AL; Chen-Tournoux A; Marshall JE; Gaggin HK; Bhardwaj A; Mohammed AA; Rehman SU; Barajas L; Barajas J; Gregory SA; Moore SA; Semigran MJ; Januzzi JL
Eur J Heart Fail; 2013 Mar; 15(3):342-51. PubMed ID: 23132825
[TBL] [Abstract][Full Text] [Related]
15. Changes in tissue-Doppler echocardiographic assessment of left ventricular filling during NT-proBNP guided heart failure treatment titration: a pilot study.
Wasywich CA; Whalley GA; Walsh HA; Gamble GD; Doughty RN
Heart Lung Circ; 2009 Feb; 18(1):38-44. PubMed ID: 18818124
[TBL] [Abstract][Full Text] [Related]
16. [NT-proBNP and echocardiography for long-term left ventricular function assessment after acute myocardial infarction treated with primary angioplasty].
Swiatkiewicz I; Grubecki A; Koziński M; Fabiszak T; Białoszyński T; Sukiennik A; Kubica J
Pol Merkur Lekarski; 2006 Mar; 20(117):289-92. PubMed ID: 16780257
[TBL] [Abstract][Full Text] [Related]
17. Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis.
Savarese G; Musella F; D'Amore C; Vassallo E; Losco T; Gambardella F; Cecere M; Petraglia L; Pagano G; Fimiani L; Rengo G; Leosco D; Trimarco B; Perrone-Filardi P
JACC Heart Fail; 2014 Apr; 2(2):148-58. PubMed ID: 24720923
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive tissue Doppler imaging pulmonary capillary wedge pressure measurement improves NT-proBNP prognostic value in heart failure.
Berni A; Cappelli F; Bitossi L; Cecioni I; Cappelli B; Toncelli L; Galanti G; Poggesi L
Acta Cardiol; 2009 Apr; 64(2):213-8. PubMed ID: 19476114
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of patients with triphasic mitral flow with a mid-diastolic L wave: prognostic role of left atrial volume and N-terminal pro-brain natriuretic peptide.
Kim SA; Son J; Shim CY; Choi EY; Ha JW
Int J Cardiovasc Imaging; 2017 Sep; 33(9):1377-1384. PubMed ID: 28349264
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease.
Baggen VJ; van den Bosch AE; Eindhoven JA; Schut AW; Cuypers JA; Witsenburg M; de Waart M; van Schaik RH; Zijlstra F; Boersma E; Roos-Hesselink JW
Circulation; 2017 Jan; 135(3):264-279. PubMed ID: 27832613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
